Autoimmune hemolytic anemia secondary prevention
|
Autoimmune hemolytic anemia Microchapters |
|
Differentiating Autoimmune hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune hemolytic anemia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Autoimmune hemolytic anemia secondary prevention |
|
Autoimmune hemolytic anemia secondary prevention in the news |
|
Directions to Hospitals Treating Autoimmune hemolytic anemia |
|
Risk calculators and risk factors for Autoimmune hemolytic anemia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
There is no significant role for secondary prevention of autoimmune hemolytic anemia.
Secondary Prevention
There is no role for secondary prevention of autoimmune hemolytic anemia. However, in patients at risk for hemolytic anemia who are suspected of having active hemolysis, screening for active hemolysis can be done via assessment of complete blood count (CBC), lactate dehydrogenase (LDH), total bilirubin, and reticulocyte count.[1]
References
- ↑ Zanella A, Barcellini W (2014). "Treatment of autoimmune hemolytic anemias". Haematologica. 99 (10): 1547–54. doi:10.3324/haematol.2014.114561. PMC 4181250. PMID 25271314.